InvestorsHub Logo

The Danish Dude

01/22/21 5:50 AM

#349309 RE: Umibe5690 #349307

Thanks for joining the board discussions Umibe5690. For "us" who are mainly reading each day, it is great with more postings of reason, that are countering FUD.

GL

pgsd

01/22/21 6:10 AM

#349310 RE: Umibe5690 #349307

"Investors should not draw conclusions wrt to success or failure of the trial predicated upon company silence"

I Certainly agree with this, actually a 'game changer' for me is the new endpoints which effectively address potentially serious hurdles to success created with pseudo-progression and crossover confoundment. With regards to the FDA I personally believe they will accept the changes even if later than the UK and EU. The fact is even if we only get approval initially with the UK and EU, many of us that bought in earlier [and averaged down, then up] will do extremely well. I have no doubt at all that FDA, Canada [and more to follow] will eventually approve.

Remember LP stated having "multiple home runs" There is no doubt in my mind she was referring to approval for rGBM as well. Despite the 'noise' the simple fact is the chances of success have increased significantly. Now that we are up to date with our regulatory filings, I can fully understand why LP will take her time to ensure success. Whilst we may miss out on
$$ millions of profit, let us remember she could possibly miss out on
$$ billions. I have no doubt that LP ["Go big or go home"] will win through and results of this will certainly be worth waiting a little longer for IMO. GLTA

biosectinvestor

01/22/21 12:44 PM

#349372 RE: Umibe5690 #349307

Again, exactly and absolutely agree with you on all points Umibe. There are so many reasons to be optimistic. And one might even as a kind of good feeling generally in critical decisions sometimes conclude that “no news is good news” when you’re waiting for a job or promotion. It’s not always the case. I get why they are grasping at that, but it is key, as you’ve also said, not to turn it into some sort of axiom based upon a not precisely applicable “rule”.